Skip to main content

Lymphoma

  • Chapter
  • 1117 Accesses

Part of the book series: Current Clinical Oncology ((CCO))

Abstract

In the year 2002 there was an estimated 60,900 new cases of lymphoma in the United States, with 53,900 cases of non-Hodgkin’s lymphoma (NHL) and 7000 cases of Hodgkin’s lymphoma (1). Estimated deaths in 2002 for NHL and Hodgkin’s lymphoma were 24,400 and 1400, respectively. The male to female ratio for both NHL and Hodgkin’s lymphoma is presently 1.1:1. Although the incidence of Hodgkin’s lymphoma has remained stable over the past several decades, there has been an increasing incidence of NHL in North America at a rate of approx 2 to 3% per year. NHL comprises 4% of male and female cancers in the United States, being the fifth most common malignancy among women (after breast, lung, colorectal, and uterine) and the sixth most common among men (after prostate, lung, colorectal, urinary bladder, and melanoma) (1).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Jemal A, Thomas A, Murray T, Thun M. Cancer Statistics, 2002. CA Cancer J Clin 2002;52:23–47.

    PubMed  Google Scholar 

  2. Stein H, Delsol G, Pileri S, et al. Hodgkin lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001:238–253.

    Google Scholar 

  3. Harris NL, Müller-Hermelink HK, Catovsky D, et al. Mature B-cell neoplasms. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001:119–235.

    Google Scholar 

  4. Armitage JO, Mauch PM, Harris NL, Bierman P. Non-Hodgkin’s lymphomas. In: Devita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 6th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2001:2258–2260.

    Google Scholar 

  5. Cleary ML, Smith SD, Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2 /immunoglobulin transcript resulting from the t(14;18) translocation. Cell 1986;47:19–28.

    Article  PubMed  CAS  Google Scholar 

  6. Pinkus GS. Needle biopsy in malignant lymphoma. J Clin Oncol 1996;4:2415–2416.

    Google Scholar 

  7. Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: Cotswolds meeting. J Clin Oncol 1989;7:1630–1636.

    PubMed  CAS  Google Scholar 

  8. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin’s Disease Staging Classification. Cancer Res 1971;31:1860–1861.

    PubMed  CAS  Google Scholar 

  9. Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin’s disease. International Prognostic Factors Project on Advanced Hodgkin’s disease. N Engl J Med 1998;339:1506–1514.

    Article  PubMed  CAS  Google Scholar 

  10. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med 1993;329:987–994.

    Article  Google Scholar 

  11. Santoro A, Bonfante V, Viviani S, et al. Subtotal nodal (STNI) vs. involved field (IFRT) irradiation after 4 cycles of ABVD in early stage Hodgkin’s disease (HD). Proc Am Soc Clin Oncol 1996;15:415.

    Google Scholar 

  12. Klasa RJ, Connors JM, Fairey R, et al. Treatment of early stage Hodgkin’s disease: Improved outcome with brief chemotherapy and radiotherapy without staging laparotomy. Annal Oncol 1996;7:21.

    Google Scholar 

  13. Horning SJ, Hoppe RT, Mason J, et al. Stanford-Kaiser Permanente GI study for clinical stage I and IIA Hodgkin’s disease: subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation. J Clin Oncol 1997;15:1736–1744.

    PubMed  CAS  Google Scholar 

  14. Canellos GP, Anderson JR, Propert KJ, et al. Chemotherapy for advanced Hodgkin’s disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 1992;327:1478–1484.

    PubMed  CAS  Google Scholar 

  15. Loeffler M, Brosteanu O, Hasenclever D, et al. Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin’s disease. International Database on Hodgkin’s Disease Overview Study Group. J Clin Oncol 1998;16:818–829.

    PubMed  CAS  Google Scholar 

  16. Bierman PJ, Anderson JR, Freeman MB, et al. High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin’s disease patients following first relapse after chemotherapy. Ann Oncol 1996;7:151–156.

    PubMed  CAS  Google Scholar 

  17. Reddy S, Saxena VS, Pellettiere EV, Hendrickson FR. Stage I and II non-Hodgkin’s lymphomas; long-term results of radiation therapy. Int J Radiat Oncol Biol Phys 1989;16:687–692.

    PubMed  CAS  Google Scholar 

  18. Network NCC. NCCN preliminary non-Hodgkin’s lymphoma practice guidelines. Oncology 1997;11:28–46.

    Google Scholar 

  19. Horning SJ. Treatment approaches to the low-grade lymphomas. Blood 1994;83:881–884.

    PubMed  CAS  Google Scholar 

  20. Kennedy BJ, Bloomfield CD, Kiang DT, Vosika G, Peterson BA, Theologides A. Combination versus successive single agent chemotherapy in lymphocytic lymphoma. Cancer 1978;41:23–28.

    Article  PubMed  CAS  Google Scholar 

  21. Saven A, Lee T, Kosty M, Piro L. Cladribine and mitoxantrone dose escalation in indolent non-Hodgkin’s lymphoma. J Clin Oncol 1996;14:2139–2144.

    PubMed  CAS  Google Scholar 

  22. McLaughlin P, Hagemeister FB, Romaguera JE, et al. Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma. J Clin Oncol 1996;14:1262–1268.

    PubMed  CAS  Google Scholar 

  23. Solal-Celigny P, Lepage E, Brousse N, et al. Recombinant interferon alpha-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. N Engl J Med 1993;329:1608–1614.

    Article  PubMed  CAS  Google Scholar 

  24. McLaughlin P, Grillo-Lopez A, Link BK, et al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four dose treatment program. J Clin Oncol 1998;16:2825–2833.

    PubMed  CAS  Google Scholar 

  25. Witzig TE, Flinn IW, Gordon LI, et al. Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin’s lymphoma. J Clin Oncol 2002;20:3262–3269

    Article  PubMed  CAS  Google Scholar 

  26. Verdonck LF, Dekker AW, Lokhorst HM, Petersen EJ, Nieuwenhuis HK. Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin’s lymphoma. Blood 1997;90:4201–4205.

    PubMed  CAS  Google Scholar 

  27. Chen MG, Prosnitz LR, Gonzalez-Serva A, Fischer DB. Results of radiotherapy in control of stage I and II non-Hodgkin’s lymphoma. Cancer 1979;43:1245–1254.

    Article  PubMed  CAS  Google Scholar 

  28. Shenkier TN, Voss N, Fairey R, et al. Brief chemotherapy and involved-region irradiation for limited-stage diffuse large cell lymphoma: an 18-year experience from the British Columbia Cancer Agency. J Clin Oncol 2001;20:197–204.

    Article  Google Scholar 

  29. Horning SJ, Glick JH, Kim K, et al. Final report of E1484: CHOP v CHOP + Radiotherapy (RT) for limited stage diffuse aggressive lymphoma. Blood 2001;98:724a.

    Google Scholar 

  30. Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma. N Engl J Med 1993;328:1002–1006.

    Article  PubMed  CAS  Google Scholar 

  31. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma. N Engl J Med 2002;346:235–242.

    Article  PubMed  CAS  Google Scholar 

  32. Haioun C, LePage E, Gisselbrecht C, et al. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poorrisk aggressive non-Hodgkin’s lymphoma: updated results of the prospective study LNH87-2. Group d’Etude des Lymphomes de l’Adulte. J Clin Oncol 1997;15:1131–1137.

    PubMed  CAS  Google Scholar 

  33. Velasquez WS, McLaughlin P, Tucker S, et al. ESHAP-an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4 year follow-up study. J Clin Oncol 1994;12:1169–1176.

    PubMed  CAS  Google Scholar 

  34. Moskowitz CH, Bertino JR, Glassman JR, et al. Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin’s lymphoma. J Clin Oncol 1999;17:3776–3785.

    PubMed  CAS  Google Scholar 

  35. Philip T, Guglielmi C, Hagenbeek A, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma. N Engl J Med 1995;333:1540–1545.

    Article  PubMed  CAS  Google Scholar 

  36. Magrath IT, Adde M, Shad A, et al. Adults and children with small non-cleaved cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 1996;14:925–934.

    PubMed  CAS  Google Scholar 

  37. Hoelzer D, Ludwig WD, Thiel E, et al. Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 1996;87:495–508.

    PubMed  CAS  Google Scholar 

  38. Chade HO. Metastatic tumours of the spine and spinal cord. In: Vinkers PJ, Bruyn GW, eds. Handbook of Clinical Neurology. Vol 20. Amsterdam: North Holland; 1976:415–433.

    Google Scholar 

  39. Spagnoli I, Gattoni F, Viganotti G. Roentgenographic aspects of non-Hodgkin’s lymphomas presenting with osseous lesions. Skeletal Radiol 1982;8:39–41.

    Article  PubMed  CAS  Google Scholar 

  40. Eustace S, O’Regan R, Graham D, Carney D. Primary multifocal skeletal Hodgkin’s disease confined to bone. Skeletal Radiol 1995;24:61–63.

    Article  PubMed  CAS  Google Scholar 

  41. Salvati M, Cervoni L, Artico M, Raco A, Ciappetta P, Delfini R. Primary spinal epidural non-Hodgkin’s lymphomas: a clinical study. Surg Neurol 1996;46:339–343.

    Article  PubMed  CAS  Google Scholar 

  42. Epelbaum R, Haim N, Ben-Shahar M, Ben-Arie Y, Feinsod M, Cohen Y. Non-Hodgkin’s lymphoma presenting with spinal epidural involvement. Cancer 1986;58:2120–2124.

    Article  PubMed  CAS  Google Scholar 

  43. Lyons MK, O’Neill BP, Kurtin PJ, Marsh WR. Diagnosis and management of primary spinal epidural non-Hodgkin’s lymphoma. Mayo Clin Proc 1996;71:453–457.

    PubMed  CAS  Google Scholar 

  44. Haddad P, Thaell JF, Kiely JF, et al. Lymphoma of the spinal epidural space. Cancer 1976;38:1862–1866.

    Article  PubMed  CAS  Google Scholar 

  45. Oviatt DL, Kirshner HS, Stein RS. Successful chemotherapeutic treatment of epidural compression in non-Hodgkin’s lymphoma. Cancer 1982;49:2446–2448.

    Article  PubMed  CAS  Google Scholar 

  46. Higgins SA, Peschel RE. Hodgkin’s disease with spinal cord compression. A case report and a review of the literature. Cancer 1995;75:94–98.

    Article  PubMed  CAS  Google Scholar 

  47. Perry JR, Deodhare SS, Bilbao JM, Murray D, Muller P. The significance of spinal cord compression as the initial manifestation of lymphoma. Neurosurgery 1993;32:157–162.

    Article  PubMed  CAS  Google Scholar 

  48. Slager UT, Kaufman RL, Cohen KL, Tuddenham WJ. Primary lymphoma of the spinal cord. J Neuropathol Exp Neurol 1982;41:437–445.

    Article  PubMed  CAS  Google Scholar 

  49. Iizuka H, Nakamura T, Kato M. Malignant lymphoma of the spinal epidural space: report of three cases. Neurol Med Chir 1989;29:307–311.

    Article  CAS  Google Scholar 

  50. Pels H, Vogt I, Klockgether T, Schlegel U. Primary non-Hodgkin’s lymphoma of the spinal cord. Spine 2000;25:2262–2264.

    Article  PubMed  CAS  Google Scholar 

  51. Barnard M, Perez-Ordonez B, Rowed DW, Ang LC. Primary spinal epidural mantle cell lymphoma: case report. Neurosurgery 2000;47:1239–1241.

    Article  PubMed  CAS  Google Scholar 

  52. McDonald AC, Nicoll JA, Rampling RP. Non-Hodgkin’s lymphoma presenting with spinal cord compression; a clinicopathological review of 25 cases. Eur J Cancer 2000;36:207–213.

    Article  PubMed  CAS  Google Scholar 

  53. Margulies JY, Kenan S, Michowitz SD, et al. Cord compression as the presenting symptom of extradural malignant lymphoma. Arch Orthop Trauma Surg 1987;106:291–296.

    Article  PubMed  CAS  Google Scholar 

  54. Toner GC, Holmes R, Sinclair RA, Tang SK, Schwarz MA. Central nervous system lymphoma: primary lumbar nerve root infiltration. Acta Haematol 1989;81:44–47.

    PubMed  CAS  Google Scholar 

  55. Maiuri F, Gangemi M, Giamundo A, Iaconetta G, De Chiara AR. Primary spinal epidural lymphomas. Acta Neurol (Napoli) 1988;10:213–219.

    CAS  Google Scholar 

  56. Mascalchi M, Torselli P, Falaschi F, Dal Pozzo G. MRI of spinal epidural lymphoma. Neuroradiology 1995;37:303–307.

    Article  PubMed  CAS  Google Scholar 

  57. Mullins GM, Flynn JP, el-Mahdi AM, McQueen JD, Owens AH Jr. Malignant lymphoma of the spinal epidural space. Ann Intern Med 1971;74:416–423.

    PubMed  CAS  Google Scholar 

  58. Russell DS, Rubinstein LJ. Pathology of Tumours of the Nervous System. 5th ed. Baltimore, MD: Williams and Wilkins; 1989:608–615.

    Google Scholar 

  59. Rao TV, Narayanaswamy KS, Shankar SK, Deshpande DH. “Primary” spinal epidural lymphomas: a clinico-pathological study. Acta Neurochir (Wien) 1982;62:307–317.

    Article  CAS  Google Scholar 

  60. Raco A, Cervoni L, Salvati M, Delfini R. Primary spinal epidural non-Hodgkin’s lymphomas in childhood: a review of 6 cases. Acta Neurochir (Wien) 1997;139:526–528.

    Article  CAS  Google Scholar 

  61. Wong ET, Portlock CS, O’Brien JP, DeAngelis LM. Chemosensitive epidural spinal cord disease in non-Hodgkins lymphoma. Neurology 1996;46:1543–1547.

    PubMed  CAS  Google Scholar 

  62. Ron IG, Reider I, Wigler N, Chaitchik S. Primary spinal epidural non-Hodgkin’s lymphoma. The contribution of nuclear magnetic resonance imaging, therapeutic approach and review of the literature. Tumori 1992;78:397–402.

    PubMed  CAS  Google Scholar 

  63. Mora J, Wollner N. Primary epidural non-Hodgkin lymphoma: Spinal cord compression syndrome as the initial form of presentation in childhood non-Hodgkin lymphoma. Med Pediatr Oncol 1999;32:102–105.

    Article  PubMed  CAS  Google Scholar 

  64. Cappellani G, Giuffre F, Tropea R, et al. Primary spinal epidural lymphomas. Report of ten cases. J Neurosurg Sci 1986;30:147–151.

    PubMed  CAS  Google Scholar 

  65. Laing RJ, Jakubowski J, Kunkler IH, Hancock BW. Primary spinal presentation of non-Hodgkin’s lymphoma. A reappraisal of management and prognosis. Spine 1992;17:117–120.

    Article  PubMed  CAS  Google Scholar 

  66. Dimarco A, Campostrini F, Garusi GF. Non-Hodgkin’s lymphomas presenting with spinal epidural involvement. Acta Oncol 1989;28:485–488.

    Article  CAS  Google Scholar 

  67. Herbst KD, Corder MP, Justice GR. Successful therapy with methotrexate of a multicentric mixed lymphoma of the central nervous system. Cancer 1976;38:1476–1478.

    Article  PubMed  CAS  Google Scholar 

  68. Mitsumoto H, Breuer AC, Lederman RJ. Malignant lymphoma of the central nervous system: a case of primary spinal intramedullary involvement. Cancer 1980;46:1258–1262.

    Article  PubMed  CAS  Google Scholar 

  69. Hautzer NW, Aiyesimoju A, Robitaille Y. “Primary” spinal intramedullary lymphomas: a review. Ann Neurol 1983;14:62–66.

    Article  PubMed  CAS  Google Scholar 

  70. Itami J, Mori S, Arimizu N, Inoue S, Lee M, Uno K. Primary intramedullary spinal cord lymphoma: report of a case. Jpn J Clin Oncol 1986;16:407–412.

    PubMed  CAS  Google Scholar 

  71. Schild SE, Wharen RE Jr, Menke DM, Folger WN, Colon-Otero G. Primary lymphoma of the spinal cord. Mayo Clin Proc 1995;70:256–260.

    PubMed  CAS  Google Scholar 

  72. Lim CC, Chong BK. Spinal epidural non-Hodgkin’s lymphoma: case reports of three patients presenting with spinal cord compression. Singapore Med J 1996;37:497–500.

    PubMed  CAS  Google Scholar 

  73. Citow JS, Rini B, Wollmann R, Macdonald RL. Isolated, primary extranodal Hodgkin’s disease of the spine: case report. Neurosurgery 2001;49:453–456.

    Article  PubMed  CAS  Google Scholar 

  74. Moridaira K, Handa H, Murakami H, et al. Primary Hodgkin’s disease of the bone presenting with an extradural tumor. Acta Haematol 1994;92:148–149.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press, Inc., Totowa, NJ

About this chapter

Cite this chapter

Sobecks, R.M. (2006). Lymphoma. In: McLain, R.F., Lewandrowski, KU., Markman, M., Bukowski, R.M., Macklis, R., Benzel, E.C. (eds) Cancer in the Spine. Current Clinical Oncology. Humana Press. https://doi.org/10.1007/978-1-59259-971-4_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-971-4_14

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-074-8

  • Online ISBN: 978-1-59259-971-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics